Document is current

Article History

Accepted: 5 September 2019

First Online: 26 October 2019

Compliance with ethical standards

:

: Ms Nikaï and Edson-Heredia, and Drs Zhu, Goldblum, Carlier, Burge, Lin, and Hollister are employees of Eli Lilly and Company and own stock. Professor Langley is a consultant for AbbVie, Amgen, Celgene, Pfizer, Janssen, Boehringer Ingleheim, LEO Pharma, and Valeant. He has received grants/has pending grants, has received honoraria, has received payment for development of educational programs including speaker bureau service, and received expenses covered or reimbursed for travel from AbbVie, Amgen, Celgene, Pfizer, Janssen, Boehringer Ingleheim, and LEO Pharma. Professor Reich has served as advisor and/or paid speaker for and/or participated in clinical trials sponsored by AbbVie, Affibody, Almirall, Amgen, Avillion, Biogen, Boehringer Ingelheim Pharma, Celgene, Centocor, Covagen, Forward Pharma, Fresenius Medical Care, Galapagos, GlaxoSmithKline, Janssen-Cilag, Kyowa Kirin, LEO Pharma, Eli Lilly and Company, Medac, Merck Sharp & Dohme Corp., Novartis, Miltenyi Biotec, Ocean Pharma, Pfizer, Regeneron, Samsung Bioepis, Sanofi, Sun Pharma, Takeda, UCB, Valeant, and XenoPort. Dr Feldman reports that a third party that was supported by Eli Lilly and Company assisted with manuscript preparation. He is a consultant for Eli Lilly and Company, Novartis, Janssen, and Celgene. He received Honoria from Eli Lilly and Company, AbbVie, Celgene, Janssen, and Novartis. He reports grant support or pending grant support from Eli Lilly and Company, Novartis, Janssen, AbbVie, and Celgene (support paid to institution). Dr. Strand reports consulting fees from Eli Lilly and Company, AbbVie, Amgen, Anthera, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, EMD Serono, Genentech/Roche, GSK, Janssen, Novartis, Pfizer, Regeneron, Sanofi, UCB, outside the submitted work. Dr Paul has received grant support from ADERMI. He reports honoria and reimbursed travel expenses from AbbVie, Boerhinger, Celgene, Eli Lilly and Company, Janssen Cilag, Almirall, Regeneron, Sanofi, Novartis, Pfizer, LEO Pharma, and Pierre Fabre. Dr Gordon received research support from AbbVie, Boehringer Ingelheim, Celgene, Eli Lilly and Company, Novartis, and Jannsen. He has received consulting fees or honoraria from AbbVie, Amgen, Boehringer Ingelheim, Celgene, Dermira, Novartis, Janssen, and Eli Lilly and Company. Dr Richard Warren has actively consulted for AbbVie, Almiral, Amgen, Boehringer Ingelheim, Celgene, Pfizer, Novartis, Janssen, LEO Pharma, XenPort, Eli Lilly and Company, and UCB. Dr Warren’s institution has grants/grants pending from LEO Pharma, AbbVie, Novartis, and Eli Lilly and Company. Dr Warren has received an honorarium from AbbVie, Almiral, Amgen, Boehringer Ingelheim, Celgene, Pfizer, Novartis, Janssen, LEO Pharma, XenPort, Eli Lilly and Company, and UCB. Dr Toth has served as an investigator or speaker for Abbvie, Amgen, BMS, Boehringer Ingelheim, Celgene, Elli Lilly and Company, Incyte, Janssen, Leo Pharma, Novartis, Pfizer, Regeneron, Sanofi-Genzyme, and UCB. M. Augustin has served as a consultant and/or paid speaker for and/or has received research grants and/or honoraries for consulting and/or scientific lectures for and/or received travel expense reimbursement and/or participated in clinical trials sponsored by companies that manufacture drugs used for treatment of psoriasis including AbbVie, Almirall, Amgen, Biogen (Biogen Idec), Boehringer Ingelheim, Celgene, Centocor, Eli Lilly and Company, Janssen-Cilag, LEO Pharma, Medac, MSD (formerly Essex, Schering-Plough), Mundipharma, Novartis, Pfizer, (formerly Wyeth), Pohl Boskamp, Sandoz, and XenoPort.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committees and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.